Showing results (41-50 of 220) with videos related to
Sort By:
Pageof 22
The Journal of Chemical Physics|February 24, 2017
Partition-DFT on the water dimerSara Gómez, Jonathan Nafziger, Albeiro Restrepo, et al.Plant Physiology|March 1, 1983
Effects of aspartate and other compounds on glyphosate uptake and growth inhibition in cultured carrot cellsE D Nafziger, J M Widholm, F W SlifeArchives of Physical Medicine and Rehabilitation|February 1, 1992
Passive exercise system: effect on muscle activity, strength, and lean body massN A Nafziger, S B Lee, S Q HuangEuropean Journal of Immunology|January 1, 1990
Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursorsJ Nafziger, M Arock, J J Guillosson, et al.The Journal of Antimicrobial Chemotherapy|June 26, 1999
Lack of effect of dirithromycin on theophylline pharmacokinetics in healthy volunteersS A McConnell, A N Nafziger, G W AmsdenJournal of Clinical Pharmacology|January 25, 2006
Limited sampling models for oral midazolam: midazolam plasma concentrations, not the ratio of 1-hydroxymidazolam to midazolam plasma concentrations, accurately predicts AUC as a biomarker of CYP3A activityLois S Lee, Joseph S Bertino, Anne N NafzigerPharmacogenetics|May 10, 2000
Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probesD S Streetman, J S Bertino, A N NafzigerAntimicrobial Agents and Chemotherapy|July 14, 1998
Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organismsA D Kashuba, J S Bertino, A N NafzigerThe American Journal of Medicine|January 9, 2003
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugsJanyce F Rogers, Anne N Nafziger, Joseph S BertinoAntimicrobial Agents and Chemotherapy|May 1, 1997
Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosingD J Demczar, A N Nafziger, J S BertinoPageof 22